NEURACTHEL

Non-medicated cosmetics; cosmetics for protecting againstlight and UV; cosmetics, namely, cosmetic products as leave-on, lotions,creams, ointments and other formulations as well as cosmetic productsfor topical use; non-medicated *skin care* preparations for protecting theskin against light and UV; non-medicated skin *care* photoprotectionpreparations; *non-medicated* sun care preparations for cosmetic use;sun-tanning preparations; *cosmetic* suntan lotions; suntan oils *forcosmetic purposes;* tanning gels; cosmetic preparations for skin carecontaining analogues of melanocyte stimulating hormone (MSH), inparticular afamelanotide; cosmetics for tanning the skin containinganalogues of melanocyte stimulating hormone (MSH), in particularafamelanotide; cosmetic preparations for tanning the skin withoutsunlight containing analogues of melanocyte stimulating hormone(MSH), in particular afamelanotide; sun screen preparations; cosmeticpreparations for protecting the skin from the sun's rays; cosmetics forprotecting the skin from sunburn; sun protecting creams; sun *blockpreparations;* sun block; sun blocking preparations; sun-block lotions;sun blocking oils; SPF sun block sprays; *lip balm with sun block;* sunblocking lipsticks; *cosmetic sunscreen preparations;* waterproofsunscreen *preparations;* water-resistant sunscreen *preparations;*sunscreen preparations; sunscreen creams; sunscreen lotions;sunscreen sticks; cosmetic foams containing sunscreen *preparations;sunscreen* preparations for protecting the hair from the sun; *nonmedicated cosmetic preparations against sunburns;* non-medicated *sun care preparations* for skin care after exposure to the sun's rays.

Pharmaceuticals *for the prevention and treatment of neurological, endocrinological, and degenerative disorders;* pharmaceutical drugs *for the prevention and treatment of epidermal problems, and damaged skin and tissue;* pharmaceutical products for endocrine, neuroendocrine, systemic, inflammatory, and acute disorders such as sepsis, shock, haemorrhagic shock, acute bleeding disorders, and chronic disorders requiring prevention, curative or palliative treatment where no other treatments are effective or safe; pharmaceutical preparations *for the prevention and treatment of viral, metabolic, genetic, endocrine, musculoskeletal, ophthalmic, cardiovascular, cerebrovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, and immune system related diseases and disorders;* pharmaceuticals used for cerebrovascular accidents *in the nature of strokes*; pharmaceutical preparations for the prevention and treatment of arterial ischemic strokes; medicines for the treatment of cardiovascular and cerebrovascular diseases; pharmaceutical preparations for the prevention and treatment of cardiovascular and cerebrovascular diseases; cardiovascular drugs for use in treating hypertension; cardiovascular preparations *for the prevention and treatment of cardiometabolic conditions;* cardiovascular pharmaceuticals *for the prevention and treatment of ischemic syndromes;* cardiovascular pharmaceutical preparations *for the prevention and treatment of cardiomyopathies;* cardiovascular agents for medical purposes; cardiovascular drugs used in treating *cardiogenic shocks;* cardiovascular drugs used in myocardial infarctions; cardiovascular drugs used in treating arrhythmias; cardiovascular drugs used in angina pectoris; cardiovascular drugs used in treating congestive heart failure (CHF); pharmaceutical preparations containing analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; medicated sun care preparations, namely, sun tanning preparations for pharmaceutical purposes containing analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; pharmaceutical preparations for skin care; pharmaceutical preparations for treating skin disorders; *dermatologicals, namely, dermatological preparations, dermatological pharmaceutical substances, dermatological pharmaceutical products;* medicinal creams for the protection of the skin; skin care creams for medical use; skin care preparations for medical use; medicated skin creams and lotions; medicated *skin care* creams for application after exposure to the sun; pharmaceutical skin lotions; preparations for cleansing the skin for medical use; *medicated chemical and biological skin care preparations and chemical reagents* for medical purposes which contain analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; *drug afamelanotide in aqueous and gel formulations;* pharmaceutical implants *comprising living tissue;* subcutaneous implants containing *living tissue and also containing* afamelanotide; implantable *subcutaneous drug delivery devices sold filled with pharmaceutical preparations for the prevention and treatment of neurological, endocrinological, and degenerative disorders; implantable subcutaneous drug delivery devices sold filled with pharmaceutical preparations and containing afamelanotide for the prevention and treatment of skin related diseases and disorder*

Medical apparatus, devices and instruments *for accessingsubcutaneous structures of the human body for the purpose ofadministering medical treatment;* apparatus for drug administration,*namely, drug delivery catheters;* devices for use in the administrationof pharmaceuticals, namely, implantable drug delivery ports; controlledrate release apparatus for dispensing pharmaceutical substances,*namely, implantable drug delivery pumps;* medical fluid injectors;injection syringes; medical syringes; implantable subcutaneous drugdelivery *ports and pumps*